tetramethylammonium has been researched along with verapamil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amigorena, S; Choquet, D; Fridman, WH; Korn, H; Teillaud, JL | 1 |
| Gupta, S | 1 |
2 other study(ies) available for tetramethylammonium and verapamil
| Article | Year |
|---|---|
Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels.
Topics: 4-Aminopyridine; Animals; Antibodies, Monoclonal; B-Lymphocytes; Cell Cycle; Electric Conductivity; Lipopolysaccharides; Lymphocyte Activation; Mice; Potassium Channels; Quaternary Ammonium Compounds; Quinine; Tetraethylammonium; Tetraethylammonium Compounds; Thymidine; Time Factors; Verapamil | 1990 |
Autologous mixed-lymphocyte reaction in man. XVII. In vitro effect of ion channel-blocking agents on the autologous mixed-lymphocyte response.
Topics: 4-Aminopyridine; Aminopyridines; Dose-Response Relationship, Drug; Humans; Interleukin-2; Ion Channels; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Quaternary Ammonium Compounds; Quinine; Receptors, Immunologic; Receptors, Interleukin-2; Recombinant Proteins; T-Lymphocytes; Tetraethylammonium; Tetraethylammonium Compounds; Verapamil | 1987 |